◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › MYGN

Myriad Genetics, Inc. (MYGN) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-07-21

Myriad Genetics, Inc. (MYGN) operates in the Diagnostics & Research industry and is headquartered in Salt Lake City, United States with about 2,700 employees. Its market capitalization is roughly $559 million. In the fiscal year ended 2025-12-31, MYGN reported $824M in revenue and ($366M) in net income.

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics.

Interactive charts & full statements → Open the MYGN valuation workbench →

MYGN Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$824M$838M$753M$678M
Gross Profit$577M$585M$517M$476M
Operating Income (EBIT)($68M)($88M)($145M)($124M)
Net Income($366M)($127M)($263M)($112M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MYGN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$200M$210M$206M$213M$196M
Gross Profit$138M$147M$144M$152M$134M
Operating Income (EBIT)($25M)($3M)($23M)($12M)($29M)
Net Income($34M)($8M)($27M)($330M)($0M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MYGN Free Cash Flow History

MYGN Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$707M$1.0B$1.1B$1.2B
Total Liabilities$339M$326M$363M$313M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MYGN viewer.

Other Companies in Diagnostics & Research

← MYFWAll stocksMYI →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.